Skip to main content
Current Therapeutic Research, Clinical and Experimental logoLink to Current Therapeutic Research, Clinical and Experimental
. 2022 Apr 2;96:100664. doi: 10.1016/j.curtheres.2022.100664

Corrigendum to ``Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats'' [Current Therapeutic Research Volume 95, 2021, 100647]

Mohammed Fouad Shalaby 1,, Hekma A Abd El Latif 2, Mohamed El Yamani 2, May Ahmed Galal 2, Sherifa Kamal 3, Ikhlas Sindi 4
PMCID: PMC9846453  PMID: 36685732

The authors regret <for the incorrect affiliation of Dr. Ikhlas Sindi, in the published article titled Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats, The corrected authors` affiliations are shown above>.

The authors would like to apologise for any inconvenience caused.


Articles from Current Therapeutic Research, Clinical and Experimental are provided here courtesy of Elsevier

RESOURCES